Glaxo has a wholly owned subsidiary—Biddie Sawyer Limited (Biddie). Both the companies follow financial year as their accounting year. The summary of separate balance sheets of both the companies as on 31st December 2017 and the statement of profit and loss statement for the year ended on that date are given below:

Standalone Balance Sheet as on 31st March 2017

Standalone Statement of Profit and Loss for the Year Ended 31st March 2017

Additional Information

1. The entire share capital of Biddie Sawyer Limited is held by GlaxoSmithKline Limited which was acquired at a cost of ₹ 4,761 lakh. The pre­acquisition reserves and surplus of Biddie stood at ₹ 4,665 lakh. 

2. The net receivables by Biddie from Glaxo from on the date of the balance sheet stood at ₹73 lakhs included in trade receivables of Biddie and other current financial liabilities of Glaxo. 

3. The revenue from operations of Glaxo include ₹24 lakhs earned from Biddie. The same amount has been included in other expenses of Biddie. 

Based upon the above information, you are required to prepare the consolidated balance sheet for Glaxo Smith Kline Limited as on 31st December 2017 and the consolidated statement of profit and loss for the year ended 31st December 2017. 

Transcribed Image Text:

Particulars ASSETS Non-current assets. Property, plant and equipment Capital work-in-progress Investment properties Intangible assets under development Investments subsidiary Financial assets (i) Investments (ii) Loans (iii) Other financial assets Income tax assets Deferred tax assets (net) Other non-current assets Total non-current assets Current assets Inventories Financial assets (i) Investments (ii) Trade receivables (iii) Cash and cash equivalents (iv) Bank balances other than (iii) above (v) Loans (v) Others (to be specified) Other current assets Total current assets Assets classified as held for sale Total assets EQUITY AND LIABILITIES Equity Equity share capital Other equity LIABILITIES Non-current liabilities Financial liabilities (i) Borrowings (iii) Other financial liabilities Provisions Deferred tax liabilities (Net) Other non-current liabilities Total Non-current liabilities. Current liabilities Financial liabilities (i) Borrowings (ii) Trade payables (iii) Other financial liabilities Other current liabilities Provisions Current tax liabilities (net) Total current liabilities Total equity and liabilities. (in Lakhs) Glaxo 25,271 57,322 532 3,225 4,761 6 1,328 243 14,799 9,131 20,513 137,131 42,548 17,080 13,929 77,469 6,873 6,922 164,822 163 302,115 8,470 194,351 202,821 99 349 27,100 27,548 27,592 35,991 3,127 4,825 211 71,746 302,115 Biddie 2 40 448 32 68 590 32 73 163 1,651 594 2,513 3,103 96 2,530 2,626 1 125 127 301 3 47 351 3,103